4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-035222
President and CEO sold 20,000 shares at $8.23 ($164,600)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-06-07 | Sale 10b5-1 | −20,000 | $8.23 | $164,600 | 7,653,467 | D |
| Open-market sales · 20,000 sh · avg $8.23 · $164,600 | |||||||
Loading xslF345X04/doc4.xml…